Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Paxmedica Inc (NQ: PXMD )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, May 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Paxmedica Inc

< Previous 1 2 3 4 Next >
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD), Bourne Partners to Collaborate in Evaluating Future Monetization of Potential PRV
Via Investor Brand Network
Exposures Product Safety
PaxMedica Engages Bourne Partners to Explore Future Monetization of Potential Priority Review Voucher (PRV)
From PaxMedica, Inc.
Via GlobeNewswire
BioMedNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) Acquires Research Assets to Accelerate PAX-101 NDA Submission
Via Investor Brand Network
PaxMedica Inc. (NASDAQ: PXMD) Is ‘One to Watch’
Via Investor Brand Network
PaxMedica Appoints David Hough M.D. as Chief Medical Officer
Announces Additional Management Changes; Independent Directors Now Majority of Board 
Via NewMediaWire
PaxMedica Acquires Suramin Research Assets from Rediscovery Life Sciences to Accelerate NDA Submission for PAX-101
From PaxMedica, Inc.
Via GlobeNewswire
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Reports on 1-for-17 Reverse Stock Split
Via Investor Brand Network
PaxMedica Announces 1-for-17 Reverse Stock Split
From PaxMedica, Inc.
Via GlobeNewswire
PaxMedica to Join Fireside Chat with PCG Advisory Following Positive Top Line Results from PAX-HAT-301 Study
Via ACCESSWIRE
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Reports on Publication of Low-Dose Suramin for ASD Research
Via Investor Brand Network
PaxMedica Inc.’s (NASDAQ: PXMD) CEO and Corporate Communications Chief Discuss Regulatory Strategy for Lead Drug Candidate and Future Plans in Recent Bell2Bell Podcast Interview
Via Investor Brand Network
BioMedNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) Clearing Path to Submit NDA for PAX-101
Via Investor Brand Network
Exposures Product Safety
PaxMedica's Research on Low Dose Suramin for Autism Spectrum Disorder Accepted for Publication
From PaxMedica, Inc.
Via GlobeNewswire
PaxMedica Holds Important FDA Type-B Meeting to Review PAX-101 Pivotal Trial Data
Via ACCESSWIRE
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Spotlighted in Latest Episode of Bell2Bell Podcast
Via Investor Brand Network
BioMedNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) Featured in Bell2Bell Podcast
Via Investor Brand Network
PaxMedica Inc. (NASDAQ: PXMD) Announces Gold Sponsorship for The BRAIN Foundation’s Synchrony Symposia 2023
Via Investor Brand Network
PaxMedica Inc. (NASDAQ: PXMD) CEO Presents ASD Pipeline and Corporate Presentation at H.C. Wainwright 25th Annual Global Investment Conference
Via Investor Brand Network
BioMedNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) to Serve as Gold Sponsor of Synchrony Symposia 2023
Via Investor Brand Network
PaxMedica Announces Gold Sponsorship of The BRAIN Foundation's Synchrony Symposia 2023
Via ACCESSWIRE
PaxMedica Inc. (NASDAQ: PXMD) Releases Compelling Video:  Progress Report on ASD and Hope for the Future
Via Investor Brand Network
BioMedNewsBreaks – Why PaxMedica Inc. (NASDAQ: PXMD) Is ‘One to Watch’
Via Investor Brand Network
Exposures COVID-19
PaxMedica to Present at the H.C. Wainwright 25th Annual Global Investment Conference
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
PaxMedica, Inc. Announces Second Quarter 2023 Financial Results and Business Update
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
PaxMedica Grants Exclusive Pharmacy Distribution Rights for PAX-101 to Vox Nova, LLC
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
PaxMedica Comments on Common Stock Volatility
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
PaxMedica CEO Interviewed by The BRAIN Foundation
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
PaxMedica Submits Clinical Trial Request in Autism Spectrum Disorder
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Economy
Exposures Supply Chain
InvestorNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) Celebrates Listing and Autism Awareness
Via Investor Brand Network
Exposures COVID-19
PaxMedica, Inc. Provides First Quarter 2023 Business Update; Phase 3 HAT-301 Top Line Results Expected in Second Half 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.